Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1972 Dec;6(6):945–951. doi: 10.1128/iai.6.6.945-951.1972

Enhancement of Hemagglutination Inhibition by Complement 1

Paul W Reno a,2, Edward M Hoffmann a
PMCID: PMC419316  PMID: 4674079

Abstract

Experiments were conducted to determine the effect of specific antibody and complement on hemagglutination inhibition of influenza virus. It was found that early immunoglobulin M antibody to influenza virus inhibited the hemagglutinating capacity of the virus. When fresh guinea pig serum was added, the inhibiting capacity of the serum was elevated from four- to eightfold When guinea pig serum was treated with known complement inhibitors, it lost its capacity to enhance hemagglutination. The use of functionally purified complement components indicated that the first, second, and fourth components were necessary and sufficient for enhancement of hemagglutination inhibition by specific antibody to influenza virus.

Full text

PDF
945

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckley P. M., Pilcher K. S. Isolation of 14C-labeled influenza virus from tissue culture, using Ecteola cellulose for final purification. Arch Gesamte Virusforsch. 1967;21(3):454–458. doi: 10.1007/BF01241744. [DOI] [PubMed] [Google Scholar]
  2. Daniels C. A., Borsos T., Rapp H. J., Snyderman R., Notkins A. L. Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A. 1970 Mar;65(3):528–535. doi: 10.1073/pnas.65.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gordon J., Whitehead H. R., Wormall A. The Action of Ammonia on Complement. The Fourth Component. Biochem J. 1926;20(5):1028–1035. doi: 10.1042/bj0201028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Götze O., Müller-Eberhard H. J. Lysis of erythrocytes by complement in the absence of antibody. J Exp Med. 1970 Nov;132(5):898–915. doi: 10.1084/jem.132.5.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kendall F. E. STUDIES ON SERUM PROTEINS. I. IDENTIFICATION OF A SINGLE SERUM GLOBULIN BY IMMUNOLOGICAL MEANS. ITS DISTRIBUTION IN THE SERA OF NORMAL INDIVIDUALS AND OF PATIENTS WITH CIRRHOSIS OF THE LIVER AND WITH CHRONIC GLOMERULONEPHRITIS. J Clin Invest. 1937 Nov;16(6):921–931. doi: 10.1172/JCI100918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Krizanová O., Rathová V. Serum inhibitors of myxoviruses. Curr Top Microbiol Immunol. 1969;47:125–151. doi: 10.1007/978-3-642-46160-6_6. [DOI] [PubMed] [Google Scholar]
  7. LINSCOTT W. D., NISHIOKA K. COMPONENTS OF GUINEA PIG COMPLEMENT. II. SEPARATION OF SERUM FRACTIONS ESSENTIAL FOR IMMUNE HEMOLYSIS. J Exp Med. 1963 Nov 1;118:795–815. doi: 10.1084/jem.118.5.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Linscott W. D., Levinson W. E. Complement components required for virus neutralization by early immunoglobulin antibody. Proc Natl Acad Sci U S A. 1969 Oct;64(2):520–527. doi: 10.1073/pnas.64.2.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MUELLER-EBERHARD H. J., LEPOW I. H. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 May 1;121:819–833. doi: 10.1084/jem.121.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  11. NELSON R. A., Jr An alternative mechanism for the properdin system. J Exp Med. 1958 Oct 1;108(4):515–535. doi: 10.1084/jem.108.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. NISHIOKA K. Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence. J Immunol. 1963 Jan;90:86–97. [PubMed] [Google Scholar]
  13. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  14. REINHARD K. R., McGRAW J. C. Simple means of obtaining concentration of influenza hemagglutinating antigen. J Bacteriol. 1959 May;77(5):557–558. doi: 10.1128/jb.77.5.557-558.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ruddy S., Austen K. F. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3. J Immunol. 1969 Mar;102(3):533–543. [PubMed] [Google Scholar]
  16. STYK B., RATHOVA V., BLASKOVIC D. Thermolability of specific haemagglutination inhibiting antibodies against FE influenza virus and their reactivation by the addition of fresh serum. Acta Virol. 1958 Jul-Sep;2(3):179–187. [PubMed] [Google Scholar]
  17. YOSHINO K., TANIGUCHI S. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT. Virology. 1965 May;26:44–53. doi: 10.1016/0042-6822(65)90024-3. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES